NEWS
Our Latest News
ARCHIMED purchases BioVendor Group, a leading global player in advanced diagnostics
Global private equity healthcare specialist ARCHIMED announces the acquisition of BioVendor Group, a major player in advanced diagnostics, with expertise in immunology, infectious, metabolic, and autoimmune diseases as well as genetics research, expanding ARCHIMED’s numerous investments in the diagnostics industry.
ARCHIMED acquires FIM Medical, a leader in the vision, audio & respiratory medical devices market
October
15,
2024
ARCHIMED acquires Jeisys Medical, a leading developer of aesthetic medicine devices
September
11,
2024
ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products
September
4,
2024
368